Purple Biotech Stock Forecast

Hold candidate since Aug 10, 2026

The Purple Biotech Ltd. stock price gained 4.90% on the last trading day (Monday, 10th Aug 2026), rising from $1.43 to $1.50. During the last trading day the stock fluctuated 24.63% from a day low at $1.34 to a day high of $1.67. The price has risen in 6 of the last 10 days and is up by 4.17% over the past 2 weeks. Volume has increased on the last day along with the price, which is a positive technical sign, and, in total, 924 thousand more shares were traded than the day before. In total, 973 thousand shares were bought and sold for approximately $1.46 million.

The stock lies the upper part of a very wide and falling trend in the short term, and this may normally pose a very good selling opportunity for the short-term trader as reaction back towards the lower part of the trend can be expected. A break up at the top trend line at $1.57 will firstly indicate a slower falling rate, but may be the first sign of a trend shift. Given the current short-term trend, the stock is expected to fall -61.74% during the next 3 months and, with a 90% probability hold a price between $0.306 and $0.601 at the end of this 3-month period. Do note, that if the stock price manages to stay at current levels or higher, our prediction target will start to change positively over the next few days as the conditions for the current predictions will be broken.

PPBT Signals & Forecast

A buy signal was issued from a pivot bottom point on Wednesday, July 22, 2026, and so far it has risen 12.78%. Further rise is indicated until a new top pivot has been found. Furthermore, there is a buy signal from the 3 month Moving Average Convergence Divergence (MACD). Purple Biotech Ltd. has increased volume and follows the last lift in the price. This is considered to be a technical positive sign as volume should follow the price-formation. Higher liquidity also reduces the general risk. Some negative signals were issued as well, and these may have some influence on the near short-term development. The Purple Biotech Ltd. stock holds a buy signal from the short-term Moving Average; at the same time, however, the long-term average holds a general sell signal. Since the longterm average is above the short-term average there is a general sell signal in the stock giving a more negative forecast for the stock. On further gains, the stock will meet resistance from the long-term Moving Average at $1.53. On a fall, the stock will find some support from the short-term average at $1.46. A break-up through the long-term average will give another buy signal, while a fall below the short-term average will add another sell signal and strengthen the general signal.

Support, Risk & Stop-loss for Purple Biotech Ltd. stock

Purple Biotech Ltd. finds support from accumulated volume at $1.47 and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.

This stock has average movements during the day and with good trading volume, the risk is considered to be medium. During the last day, the stock moved $0.330 between high and low, or 24.63%. For the last week, the stock has had daily average volatility of 16.16%.

Our recommended stop-loss: $1.44 (-4.01%) (This stock has medium daily movements and this gives medium risk. There is a buy signal from a pivot bottom found 13 days ago.)

Trading Expectations (PPBT) For The Upcoming Trading Day Of Tuesday 11th

For the upcoming trading day on Tuesday, 11th we expect Purple Biotech Ltd. to open at $1.50, and during the day (based on 14 day Average True Range), to move between $1.42 and $1.58, which gives a possible trading interval of +/-$0.151 (+/-10.58%) up or down from last closing price. If Purple Biotech Ltd. takes out the full calculated possible swing range there will be an estimated 10.58% move between the lowest and the highest trading price during the day.

Since the stock is closer to the support from accumulated volume at $1.47 (2.00%) than the resistance at $1.54 (2.67%), our systems sees the trading risk/reward intra-day as attractive and believe profit can be made before the stock reaches first resistance..

Is Purple Biotech Ltd. stock A Buy?

Purple Biotech Ltd. holds several positive signals, but we still don't find these to be enough for a buy candidate. At the current level, it should be considered as a hold candidate (hold or accumulate) in this position whilst awaiting further development. We have upgraded our analysis conclusion for this stock since the last evaluation from a Sell to a Hold candidate.

Current score: 0.645 Hold/Accumulate Upgraded

Predicted Fair Opening Price

Predicted fair opening price on August 11, 2026 - $1.50 ( 0.222%).

Want to trade but not sure how? Our step-by-step guide can help.
Skip the guide? Open account with our trusted broker*
*Your capital is at risk